Leathem S. Stearn - Sep 23, 2022 Form 3 Insider Report for Organicell Regenerative Medicine, Inc. (OCEL)

Role
Director
Signature
/s/ Dale S. Bergman as attorney-in-fact for Leathem Stearn
Stock symbol
OCEL
Transactions as of
Sep 23, 2022
Transactions value $
$0
Form type
3
Date filed
10/6/2022, 07:29 PM
Next filing
Apr 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding OCEL Common Stock, $0.001 par value 667K Sep 23, 2022 Direct
holding OCEL Common Stock, $0.001 par value 12.5M Sep 23, 2022 Held by Stearn Enterprises LLC F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OCEL Warrants to Purchase Common Stock Sep 23, 2022 Common Stock, par value $0.001 per share 1M $0.04 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is the sole beneficial owner of Stearn Enterprises, LLC.
F2 The Warrants vest in 12 monthly installments of 83,333 shares commencing on September 23, 2022.

Remarks:

Exhibit List - Exhibit 24 Power of attorney